Inventor
CONNOLLY TERRENCE JOSEPH
US13 patents
⚠️ This page may combine multiple inventors who share the name “CONNOLLY TERRENCE JOSEPH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELGENE CORP
7 patentsUS10252981B2Apr 9, 2019
Methods of synthesis of (1R,2R,5R)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful therein
CELGENE CORP3 citations70
US11780801B2Oct 10, 2023
Methods of synthesis of (1R,2R,5R)-5-amino-2-methyl-cyclohexanol hydrochloride and intermediates useful therein
CELGENE CORP0 citations62
US11192847B2Dec 7, 2021
Methods of synthesis of (1R,2R,5R)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful therein
CELGENE CORP0 citations62
US9187417B2Nov 17, 2015
Processes for the preparation of (S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethylamine
CELGENE CORP3 citations58
US10774033B2Sep 15, 2020
Methods of synthesis of (1R, 2R, 5R)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful therein
CELGENE CORP0 citations49
US9688623B2Jun 27, 2017
Processes for the preparation of (S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethylamine
CELGENE CORP0 citations48
US9586897B2Mar 7, 2017
Processes for the preparation of (S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethylamine
CELGENE CORP0 citations48
ROCHE PALO ALTO LLC
3 patentsUS6864244B2Mar 8, 2005
Anhydrous crystalline 1-[4(S)-azido-2(S),3(R)-dihydroxy-4-(hydroxymethyl)-1(R)-cyclopentyl]cytosine hemisulfate as useful as an antiviral agent
ROCHE PALO ALTO LLC27 citations91
US7244738B2Jul 17, 2007
Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists
ROCHE PALO ALTO LLC1 citations50
US7598399B2Oct 6, 2009
Methods for synthesis of 3-amino-1-arylpropyl indoles
ROCHE PALO ALTO LLC0 citations49
SIGNAL PHARM LLC
2 patentsUS9403829B2Aug 2, 2016
Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one, a solid form thereof and methods of their use
SIGNAL PHARM LLC13 citations81
US9434735B2Sep 6, 2016
Amorphous form of 4-((4-(cyclopentyloxy)-5-(2-methylbenzo[d]oxazol-6-yl)-7h-pyrrolo[2,3-d]pyrimidin-2-yl)amino)-3-methoxy-n-methylbenzamide, compositions thereof and methods of their use
SIGNAL PHARM LLC0 citations45